Fibroblast
growth factor receptor 4 (FGFR4) has been identified
as a potential target due to its transmission of the FGF19 signaling
pathway, which is critical to hepatocellular carcinoma (HCC). Therefore,
focusing on the specific Cys552 of FGFR4 subtype, we designed and
synthesized a novel family of 1,6-naphthyridin-2(1H)-one derivatives as potent and highly selective FGFR4 inhibitors.
Through detailed structural optimizations, the representative compound A34 exhibited improved FGFR4 inhibitory capability and selectivity
and excellent anti-proliferative activities against FGFR4-dependent
HCC cell lines. Additionally, A34 demonstrated remarkable
antitumor efficacy in a Hep-3B HCC xenograft model, with favorable
pharmacokinetic properties, and low risk of hERG toxicity. A34 also showed moderate inhibitory activities against the FGFR4 V550L
mutant in vitro, which indicates that it has the potential as a novel
anticancer agent for HCC.
A one-pot
and step economic reaction involving Rh(III)-catalyzed
C–H thiolation and relay Cu(II)-catalyzed C–N amination
of acetanilide and 2-bromothiophenol is reported here, with several
valuable phenothiazine products obtained. This synthesis protocol
proceeds from easily starting materials, demonstrating high atom economy,
broad substrate scope, and good yield. Furthermore, the directing
group can be easily eliminated, and chlorpromazine is provided in
a large scale; thus this synthesis protocol could be utilized to construct
phenothiazine scaffolds.
The analogous three‐component synthesis strategy for substituted 1,2,4‐oxadiazole and quinazoline derivatives from readily available benzaldehyde, benzylamine and hydroxylamine or aniline has been developed. Both the cascade reaction sequences involves nucleophilic addition of C−N bond, introduction a halogen donor, nucleophilic substitution and Cu(II)‐catalyzed aerobic oxidation. This synthesis methodology demonstrated good yields, broad substrate scope and oxygen as a green oxidant. Thus, this synthesis protocol provides strategies for the construction of substituted 1,2,4‐oxadiazole and quinazolines from readily and simple starting materials.
We established an efficient and sustainable rhodium(III)-catalyzed and ionic liquid-mediated CÀ S and CÀ Se formation from readily available starting material acetanilide with diaryl disulfides and diaryl diselenides. The CÀ H activation proceeds in ionic liquid without extra silver salt as additive, and the catalytic media can be reused for several times to accomplish the catalysts sustainable utilization. Furthermore, this synthesis protocol is suitable for a wide functional group compatibility, and the directing group can be easily removed. Most importantly it can be developed as a facile access to phenothiazine scaffold with potent biological activities, thus this strategy can be broadly applied to organic synthesis and medicinal chemistry.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.